Sponsor
ECOG-ACRIN Cancer Research Group
Clinical research sponsor
Clinical trials
40 shownTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingNCT04423211 · lead sponsor · 2020-10-08
RECRUITINGTesting the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNCT07852195 · lead sponsor · 2027-01-06
NOT_YET_RECRUITINGEvaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue SarcomaNCT06526897 · lead sponsor · 2025-01-28
NOT_YET_RECRUITINGMobile Health for Adherence in Breast Cancer PatientsNCT06112613 · lead sponsor · 2024-04-02
ACTIVE_NOT_RECRUITINGTesting the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT TrialNCT05710328 · lead sponsor · 2023-05-10
ACTIVE_NOT_RECRUITINGTo Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringNCT04597359 · lead sponsor · 2021-10-05
ACTIVE_NOT_RECRUITINGTesting the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE StudyNCT04484818 · lead sponsor · 2021-03-01
ACTIVE_NOT_RECRUITINGUsing FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE StudyNCT04316117 · lead sponsor · 2020-09-15
ACTIVE_NOT_RECRUITINGCompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyNCT04266249 · lead sponsor · 2020-03-13
ACTIVE_NOT_RECRUITINGDocetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerNCT04001829 · lead sponsor · 2019-08-09
ACTIVE_NOT_RECRUITINGMultiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate CancerNCT03697148 · lead sponsor · 2019-02-11
ACTIVE_NOT_RECRUITINGAssessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community SettingNCT03804255 · lead sponsor · 2019-01-08
WITHDRAWNAbiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelNCT03419234 · lead sponsor · 2018-04-26
ACTIVE_NOT_RECRUITINGDigital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast CancerNCT03233191 · lead sponsor · 2017-09-28
ACTIVE_NOT_RECRUITINGAbbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense BreastsNCT02933489 · lead sponsor · 2016-12-27
ACTIVE_NOT_RECRUITINGFludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by SurgeryNCT02607423 · lead sponsor · 2015-11-19
WITHDRAWNPlatinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyNCT02445391 · lead sponsor · 2015-10-20
ACTIVE_NOT_RECRUITINGMRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In SituNCT02352883 · lead sponsor · 2015-03-25
ACTIVE_NOT_RECRUITINGCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · lead sponsor · 2015-03-23
ACTIVE_NOT_RECRUITINGDocetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung CancerNCT01824901 · lead sponsor · 2014-01-15
COMPLETEDA Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)NCT01824836 · lead sponsor · 2013-06-11
ACTIVE_NOT_RECRUITINGBiomarkers in Tissue Samples From Patients With Breast Cancer Treated With BevacizumabNCT01156168 · lead sponsor · 2011-04-05
COMPLETEDBLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT00828009 · lead sponsor · 2011-01-17
COMPLETEDTamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast CancerNCT01124695 · lead sponsor · 2011-01-07
COMPLETEDBevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung CancerNCT01107626 · lead sponsor · 2010-10-25
COMPLETEDBiomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib TosylateNCT01124669 · lead sponsor · 2010-06-13
COMPLETEDBiomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With Erlotinib HydrochlorideNCT01123460 · lead sponsor · 2010-04-12
COMPLETEDBiomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in SituNCT01132560 · lead sponsor · 2010-03-05
COMPLETEDStudy of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803NCT00897351 · lead sponsor · 2008-07-10
COMPLETEDStudying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast CancerNCT00897845 · lead sponsor · 2008-06-17
COMPLETEDStudy of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and PaclitaxelNCT00900172 · lead sponsor · 2008-03-15
COMPLETEDBiomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without BevacizumabNCT00898417 · lead sponsor · 2008-03-14
COMPLETEDDevelopment of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung CancerNCT00897533 · lead sponsor · 2007-04-13
COMPLETEDAndrogen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerNCT00309985 · lead sponsor · 2006-09-26
COMPLETEDDNA Changes in Patients With Prostate CancerNCT00899184 · lead sponsor · 2006-05-23
COMPLETEDHER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598NCT00896909 · lead sponsor · 2006-02-02
COMPLETEDSelenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung CancerNCT00008385 · lead sponsor · 2000-12-18
COMPLETEDRadiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung CancerNCT06686771 · collaborator · 2025-12-16
RECRUITINGDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseNCT06592924 · collaborator · 2025-05-28
RECRUITINGProspective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC PatientsNCT06538038 · collaborator · 2024-09-17
ACTIVE_NOT_RECRUITINGSponsor roles
lead sponsor37
collaborator3
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.